- present As of December 31, 2009, the Foundation reached the following milestones in its prevention, care, and treatment initiatives: The Foundation worked in 17 countries and supported more than 4,800 sites. In 2009, more than 2.3 million women accessed Foundation-supported services for prevention of mother-to-child transmission of HIV. Since the beginning of its global programs, the Foundation has provided more than 9.2 million women with the services to prevent transmission of HIV to their babies. In six years, the Foundation's care and treatment programs, focused on children and their families, have enrolled more than 923,000 individuals, including nearly 75,000 children. Since enrollment began, more than 482,000 individuals have begun antiretroviral treatment—and more than 39,000 are children under the age of 15. Activities EGPAF works to eliminate pediatric AIDS in three ways: International Programs: Responding to the need for HIV prevention, care, and treatment services, the Foundation works in regions of the world most affected by HIV and AIDS. Working together with governments and partners, Foundation-supported programs provide a range of HIV-related services: counseling, testing, the establishment of prevention of mother-to-child transmission (PMTCT) programs, and lifelong care and treatment for children and families. Research: Foundation-funded researchers around the world work to improve HIV prevention, care, and treatment programs; to train the next generation of international pediatric HIV research leaders; and to pursue the development of a pediatric HIV vaccine. Public Policy and Global Advocacy: The Foundation’s public policy and global advocacy efforts work to challenge national governments and international organizations to commit the political and financial resources necessary to achieve the elimination of pediatric AIDS. Grants and awards The Elizabeth Glaser Pediatric AIDS Foundation provides several grants and awards to scientists performing research aimed towards the study and eradication of pediatric AIDS. The Elizabeth Glaser Scientist Award is one of the many awards that the foundation offers through a competitive award application process. Award and grant winners Margaret Feeney, M.D., M.Sc. 2006 Elizabeth Glaser Scientist Award Winner for her project, "The Immune Response to Acute Perinatal HIV Infection". Alexandra Trkola, Ph.D. 2006 Elizabeth Glaser Scientist Award Winner for her project, "The Humoral Immune Response to HIV". Jeffrey S. A. Stringer, M.D. 2002 Elizabeth Glaser Scientist Award Winner for his project, "Optimal Use of Nevirapine to Prevent Perinatal HIV". Sunil Kumar Ahuja, M.D. 2001 Elizabeth Glaser Scientist Award Winner for work on the influence of genetics on HIV/AIDS. Goals The Foundation’s